FDA approves Otezla to treat psoriatic arthritis

FDA approves Otezla to treat psoriatic arthritis

“Relief of pain and inflammation and improving physical function are important treatment goals for patients with active psoriatic arthritis,” said Curtis Rosebraugh, M.D., M.P.H., director of the Office of Drug Evaluation II in the FDA's Center for

2
Like
Save

Comments

Write a comment

*